Skip to main content
logo
TME Pharma N.V. (EPA:ALTME)
France flag France · Delayed Price · Currency is EUR
0.0708
+0.0017 (2.46%)
Apr 2, 2026, 5:26 PM CET

TME Pharma Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
0.03-----
Other Revenue
----0.030.04
Revenue
0.03---0.030.04
Revenue Growth (YoY)
-----5.71%-77.27%
Gross Profit
0.03---0.030.04
Selling, General & Admin
2.312.982.993.882.881.88
Research & Development
2.212.32.658.1510.664.02
Other Operating Expenses
-0.03-0.02-0.02-0.02-0.04-0.04
Operating Expenses
4.495.265.6212.0113.495.86
Operating Income
-4.46-5.26-5.62-12.01-13.46-5.82
Interest Expense
-0.05-0.02-0.02-0.13-0.05-0.13
Currency Exchange Gain (Loss)
-00.010.01-0.030.180.01
Other Non Operating Income (Expenses)
-0.12-0.45-1.34-3.27-1.42-4.92
EBT Excluding Unusual Items
-4.63-5.72-6.97-15.45-14.74-10.86
Other Unusual Items
0.06-0.240.320.290.45
Pretax Income
-4.58-5.72-6.73-15.13-14.45-10.41
Income Tax Expense
--00.010-
Earnings From Continuing Operations
-4.58-5.72-6.74-15.13-14.45-10.41
Minority Interest in Earnings
---000
Net Income
-4.58-5.72-6.74-15.13-14.45-10.41
Net Income to Common
-4.58-5.72-6.74-15.13-14.45-10.41
Shares Outstanding (Basic)
69365110
Shares Outstanding (Diluted)
69365110
Shares Change (YoY)
307.74%616.96%326.62%78.28%103.92%190.00%
EPS (Basic)
-0.07-0.16-1.34-12.86-21.90-32.16
EPS (Diluted)
-0.07-0.16-1.34-12.86-21.90-32.16
Free Cash Flow
-4.77-4.65-5.65-12.16-12.4-5.26
Free Cash Flow Per Share
-0.07-0.13-1.13-10.34-18.79-16.27
Gross Margin
100.00%---100.00%100.00%
Operating Margin
-16511.11%----40790.91%-16640.00%
Profit Margin
-16948.15%----43793.94%-29728.57%
Free Cash Flow Margin
-17670.37%----37560.61%-15037.14%
EBITDA
-4.5-5.24-5.59-11.99-13.44-5.81
D&A For EBITDA
-0.040.020.030.020.020.02
EBIT
-4.46-5.26-5.62-12.01-13.46-5.82
Source: S&P Global Market Intelligence. Standard template. Financial Sources.